SCHEMBL3860520

SCHEMBL3860520

Cc1cc(NC(=O)c2ccc(CCl)cc2)ccc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 14/20 0.87
ABL1 P00519 12/20 0.87
KIT P10721 9/20 0.87
BCR P11274 9/20 0.71
PDGFRB P09619 5/20 0.71
EGFR P00533 2/20 0.69
PRKCA P17252 1/20 0.69
KDR P35968 2/20 0.67
PLK4 O00444 1/20 0.67
DDX3X O00571 1/20 0.67
GAK O14976 1/20 0.67
SLC22A2 O15244 1/20 0.67
MAPK13 O15264 1/20 0.67
CA12 O43570 1/20 0.67
SLC22A3 O75751 1/20 0.67
ABCB11 O95342 1/20 0.67
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
LMNA P02545 1/20 0.67
ALB P02768 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723757 0.93 PDGFRA (1.00) PDGFRAABL1KITBCRPDGFRB
Hydrochloric Acid SCHEMBL4396677 0.92 PDGFRA (0.98) PDGFRAABL1KITBCRPDGFRB
SCHEMBL30197820 0.89 PDGFRA (0.85) PDGFRAABL1KITBCRPDGFRB
SCHEMBL3860423 0.89 PDGFRA (0.88) PDGFRAABL1KITBCRPDGFRB
SCHEMBL12034590 0.88 PDGFRA (0.77) PDGFRAABL1KITBCRPDGFRB
SCHEMBL3863391 0.88 PDGFRA (0.78) PDGFRAABL1KITBCRPDGFRB
SCHEMBL3860540 0.87 PRKCA (0.81) PDGFRAABL1KITBCRPDGFRB
SCHEMBL3869324 0.87 ABL1 (0.78) PDGFRAABL1KITBCRPDGFRB
SCHEMBL12034589 0.87 ABL1 (0.78) PDGFRAABL1KITBCRPDGFRB
SCHEMBL13845837 0.87 ABL1 (0.88) PDGFRAABL1KITBCRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595323-B2 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL YANG PHARM. CO., LTD. (KR) 2009-09-29 US disclosed
US-20040248918-A1 Anticancer agents IL YANG PHARM. CO., LTD. 2004-12-09 US disclosed
WO-2004099186-A1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM CO., LTD. (KR) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248918-A1 Anticancer agents BRDT, CHIA, RNASE1 PDGFRA 239/4885ABL1 1106/4885KIT 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.